8-K: Accuray Appoints Leonel Peralta as Senior Vice President, Chief Operations Officer

Accuray Incorporated announces the appointment of Leonel Peralta as its new Senior Vice President, Chief Operations Officer, effective February 3, 2025.

Summary

• Accuray Incorporated has appointed Leonel Peralta as the Senior Vice President, Chief Operations Officer, effective February 3, 2025.
• Mr. Peralta previously held leadership positions at Siemens Healthineers and Medtronic plc, among other companies.
• His compensation includes an annual base salary of $450,000, an $80,000 sign-on bonus, and eligibility for an annual cash incentive bonus targeted at 60% of his base salary.
• He is also eligible for a performance bonus of up to $300,000 based on achieving certain performance targets.
• Accuray will grant Mr. Peralta restricted stock units (RSUs) valued at $750,000, vesting over four years.
• The employment agreement outlines severance benefits in case of termination without cause or resignation for good reason, including a lump sum payment, prorated bonus, and COBRA reimbursement.
• Enhanced severance benefits are provided in the event of termination or resignation following a change in control of the company.

Sentiment

Score: 7

Explanation: The announcement is generally positive, indicating a strengthening of the management team with an experienced executive. The compensation package is standard for the industry, suggesting a stable and well-managed company.

Positives

• Accuray has appointed an experienced executive, Leonel Peralta, as its new COO.
• Mr. Peralta's extensive background in global operations within the medical technology industry should benefit Accuray.
• The compensation package includes performance-based incentives, aligning Mr. Peralta's interests with the company's success.

Future Outlook

The document does not contain specific forward-looking statements regarding the company's financial performance or future prospects beyond the terms of the executive's employment agreement.

Industry Context

The appointment of a seasoned operations executive from established medical technology companies like Siemens Healthineers and Medtronic suggests Accuray is focused on optimizing its operational efficiency and potentially scaling its business. This is a common strategic move in the medical device industry to improve profitability and market competitiveness.

Comparison to Industry Standards

• Executive compensation packages in the medical technology industry typically include a base salary, sign-on bonus, performance-based bonuses, and equity grants.
• The size of the compensation package is generally commensurate with the executive's experience, responsibilities, and the company's size and performance.
• For example, similar roles at companies like Varian Medical Systems (now part of Siemens Healthineers) or Elekta may offer comparable compensation structures, although the specific amounts may vary.
• The vesting schedule for RSUs (25% per year over four years) is a standard practice in the industry to incentivize long-term commitment.

Management Changes

Stakeholder Impact

• Shareholders may view the appointment positively, anticipating improved operational efficiency and strategic execution.
• Employees may experience changes in leadership and operational processes under the new COO.
• Customers and suppliers may see potential improvements in product quality and supply chain management.

Next Steps

• Mr. Peralta will assume his role as Senior Vice President, Chief Operations Officer, effective February 3, 2025.
• The full text of the Employment Agreement will be filed as an exhibit to the Company's Quarterly Report on Form 10-Q for the quarter ended March 31, 2025.

Key Dates